Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06105242 · ClinicalTrials.gov registry record
Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)
A clinical trial of CTEPH, sponsored by Intermountain Health Care.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06105242: Recruiting study of CTEPH, sponsored by Intermountain Health Care.
NCT06105242 is a study of CTEPH that is actively recruiting participants, run by Intermountain Health Care. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06105242, a study of CTEPH, is actively recruiting participants, sponsored by Intermountain Health Care.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
1. To identify biological sex differences in baseline RV function in CTEPH 2. To identify biological sex differences in recovery of RV function after PTE surgery in CTEPH 3. To determine if sex hormone levels relate to RV function at CTEPH diagnosis and during recovery after PTE.
Primary Outcome
To assess biological sex differences in baseline RV function in CTEPH
Conditions Studied
Study Locations (1)
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-05-30 |
| Est. Completion | 2026-12-31 |
What NCT06105242 shows while recruiting
NCT06105242 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 1 condition, with CTEPH appearing as the primary indexed condition, and to 0 interventions.
NCT06105242 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06105242 about?
NCT06105242 is a clinical study titled "Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)". 1. To identify biological sex differences in baseline RV function in CTEPH 2. To identify biological sex differences in recovery of RV function after PTE surgery in CTEPH 3. To determine if sex hormone levels relate to RV function at CTEPH diagnosis and during recovery after PTE.
What is the current status of trial NCT06105242?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2022-05-30. Estimated completion is 2026-12-31.
What conditions does trial NCT06105242 study?
This clinical trial studies the following conditions: CTEPH.
Who is sponsoring clinical trial NCT06105242?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06105242 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for CTEPH
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI